A reimagined New Haven landscape continues to take shape, with several projects by Yale University and prominent developers coming into focus.
Winstanley Enterprises is nearing the completion of the core shell of its 10-story tower at 101 College St., where a half-million square feet of new biotech space is on track for a completion date of August.
This $250 million life sciences building will be anchored by Arvinas, Alexion Pharmaceuticals, BioLabs and Yale University.